Biochemical and Genetic Markers in Liver Diseases

NASH: Non-invasive Diagnostic Markers and Imaging

NCT02717000 ·Status: UNKNOWN

Plasma and Hemodynamic Markers During Hepatectomy

NCT01700231 ·Status: COMPLETED

Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease

NCT02488941 ·Status: UNKNOWN

Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer

NCT01034865 ·Status: COMPLETED

Identification of Liver Fibrosis Biomarkers

NCT06819917 ·Status: RECRUITING

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

NCT05866783 ·Status: RECRUITING

Prevalence of NAFLD in T1DM Patients

NCT06445361 ·Status: RECRUITING ·Phase: NA

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

NCT07275554 ·Status: RECRUITING

Novel Biomarker Assay for Biomarker Assay for HCC Detection

NCT05494853 ·Status: NOT_YET_RECRUITING

Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma

NCT02550613 ·Status: UNKNOWN

DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE

NCT07317193 ·Status: RECRUITING ·Phase: NA

Hemostasis in Liver Cirrhosis and Hepatocellular Cancer

NCT06212635 ·Status: RECRUITING

Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC

NCT04221347 ·Status: UNKNOWN

Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis

NCT03746210 ·Status: RECRUITING

The European NAFLD Registry

NCT04442334 ·Status: RECRUITING

Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies

NCT05613621 ·Status: ACTIVE_NOT_RECRUITING

Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection

NCT05567614 ·Status: UNKNOWN

Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver Progression

NCT02267148 ·Status: COMPLETED

Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events

NCT01963949 ·Status: WITHDRAWN

An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423

NCT01316679 ·Status: COMPLETED

Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD

NCT05766449 ·Status: RECRUITING

Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B

NCT01679769 ·Status: COMPLETED

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

NCT02060565 ·Status: RECRUITING

Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.

NCT01729221 ·Status: UNKNOWN

Development of a Novel Biomarker for Liver Fibrosis

NCT02348814 ·Status: COMPLETED